Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.05 AUD | -0.07% | +0.94% | -6.06% |
Apr. 29 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |